Intellectual Property Department

The market protection
of your products.

Patents, exclusivity, trade secrets, and trademarks — six courses of the Core Curriculum cover the fundamentals of protection. 

IP Department CHair

Tom LaGrandeur

PhD, JD

Tom LaGrandeur is a USPTO-registered patent attorney with nearly 27 years of experience across law firms, tech transfer, and corporations such as Eli Lilly and Zimmer.  He holds a PhD in Molecular Biology and a JD (magna cum laude) from Indiana University. Tom has drafted foundational patents across multiple industries—including authoring a cornerstone patent for a $200M biotech acquisition—and relies on his deep experience as counsel, and as a client, to deliver top-tier legal service.

Core Curriculum

Six courses. One complete picture.

Learners who complete the Core Curriculum can participate capably in discussions about pharmaceutical and biotech patents, regulatory exclusivities, trade secrets, and trademarks.

$250 per course, or all six for $900

Save 40% with the full Intellectual Property Core Curriculum — same self-paced, on-demand access.
Expert Courses - Coming Soon

Going deeper with expert courses.

Courses build on the Core Curriculum, each taught by a practitioner with direct experience in that specialty.  They're in development now — preview what's coming and join the waitlist to hear when they open.
7Coming soon

Small Molecule Patents

  • Landscape of chemical synthesis
  • Variations on salts, phosphates, etc.
  • Successes and failures
8Coming soon

Biologic Patents

  • Evolution and status of patentability
  • Protein scopes of exclusion
  • Claim writing for RNA, DNA, and antisense
9Coming soon

Digital Health IP Strategies

  • System-embodiment protection
  • Software patents and copyrights
  • Data capture and leverage
10Coming soon

AI in Patents

  • Inventorship by AI
  • Current strategies of development
  • Information control — not feeding the beast
11Coming soon

Licensing & Transactions

  • Effective due diligence
  • Matching terms to strategy
  • Team dynamics and expectations
12Coming soon

Life Cycle Extension

  • Innovation examples and vectors
  • Visualize and time investment
  • Rx to OTC

Thank you!

Complementary Resources Available Now

Reference materials for your work.

PowerPoint for Patent Terms Course

Download the deck and modify it as you see fit to teach people in your organization, or your clients.  Review the deck with a patent attorney before finalizing and teaching it — and if you improve it, submit your changes back so we can continue to evolve the course.

WIPO Invention Disclosure Form

Your company or institution should have an established process for capturing ideas that may be patentable. Use these template forms as a starting point for working with your patent attorneys to develop your company's version, or to document new discoveries that may be patent-eligible.
Reference & Media

Stay current on IP developments.

Podcasts

Top episodes relevant to pharmaceutical and biotechnology:
  • May 10, 2022 Bob Giles – Qualcomm’s New Chief IP Counsel
  • March 15, 2022 Louis Carbonneau on Brokering Patents
  • June 29, 2021 Mark Han: Helping Innovative Doctors
Top episodes relevant to pharmaceutical and biotechnology:
  • February 1, 2023 IP Investing- What is it? Who does it? Why it Matters?
  • April 12, 2023 What Entrepreneurs and Students Need to Learn Today.
  • September 9, 2022 The Secret is Out – Trade Secrets Are Driving Competitive Advantage.
Top episodes relevant to pharmaceutical and biotechnology:
  • May 1, 2021 AI Based Prior Art Search – Open Source Project PQAI
  • January 28, 2023 Daniel Scola, Jr. Practical Trademark Tips and Strategies

In the U.S. about 200,000 patents are issued each year.

In the U.S. about 350,000 patent applications are filed each year.

There are about 8,000 patent examiners in the USPTO

USPTO Technology Center 1600 handles drug and biologic therapies and diagnostics Most patent examiners are attorneys

Patent examiners are divided among nine centers, each with a different technology focus.

The average amount of time a USPTO examiner spends with a patent is 19 hours.

Most patents have no, or very limited, commercial value.

About 3% of patents have a Patent Trials and Appeals Board hearing or litigation

Article 1, Clause 8 of the U.S. Constitution provides for a patent and trademark system

Length of time a patent lasts is 20 years plus extensions